Mirae Asset Global ETFs Holdings
PRME icon

Mirae Asset Global ETFs Holdings’s Prime Medicine PRME Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$421K Buy
122,463
+7,403
+6% +$28.2K ﹤0.01% 1970
2025
Q4 		$399K Sell
115,060
-5,363
-4% -$23.9K ﹤0.01% 2000
2025
Q3 		$667K Buy
120,423
+567
+0.5% +$2.3K ﹤0.01% 1722
2025
Q2 		$296K Buy
119,856
+85,938
+253% +$132K ﹤0.01% 2077
2025
Q1 		$67.5K Buy
33,918
+1,419
+4% +$3.62K ﹤0.01% 2777
2024
Q4 		$94.9K Buy
32,499
+1,372
+4% +$4.82K ﹤0.01% 2721
2024
Q3 		$120K Buy
31,127
+11,603
+59% +$53.7K ﹤0.01% 2624
2024
Q2 		$100K Buy
+19,524
New +$118K ﹤0.01% 2560

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's PRME Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Prime Medicine (PRME) stake by 6.4% in Q1 2026, buying an estimated $28.2K and bringing the position to 122,463 shares worth $421K. The position accounts for ﹤0.01% of the portfolio, ranked #1970.

Mirae Asset Global ETFs Holdings first reported a position in PRME in Q2 2024 and has held it in 8 quarters since. The position peaked at $667K in Q3 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 122,463 shares of Prime Medicine worth $421K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 7,403 Prime Medicine shares in Q1 2026, an estimated $28.2K.
  • Prime Medicine made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #1970 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Prime Medicine in Q2 2024 and has held it in 8 quarters since.
  • Mirae Asset Global ETFs Holdings's Prime Medicine position peaked at $667K in Q3 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.